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Abstract: Urinary tract infections (UTI) occur frequently in older people. Unfortunately, 
UTI is commonly overdiagnosed and overtreated on the basis of nonspecific clinical signs and 
symptoms. The diagnosis of a UTI in the older patient requires the presence of new urinary 
symptoms, with or without systemic symptoms. Urinalysis is commonly used to diagnose 
infection in this population, however, the evidence for its use is limited. There is   overwhelming 
evidence that asymptomatic bacteriuria should not be treated. Catheter associated urinary 
tract infection accounts for a significant amount of hospital-associated infection. Indwelling 
urinary catheters should be avoided where possible and alternatives sought. The use of narrow 
spectrum antimicrobial agents for urinary tract infection is advocated. Local guidelines are 
now widely used to reflect local resistance patterns and available agents. Guidelines need to 
be updated to reflect changes in antimicrobial prescribing and a move from broad to narrow 
spectrum antimicrobials.
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Introduction
Urinary tract infections (UTI) are one of the most common infections in the older 
population, occurring both in the community and in long-term care settings. The 
spectrum of UTI ranges from symptomatic bacteriuria to bacteremic infection. UTI 
with bacteremia has a high mortality in the older population, with studies reporting a 
28 day mortality of 5%.1
Too often, the diagnosis of UTI is made in the absence of a typical clinical history and 
signs resulting in overdiagnosis and overtreatment.2 Studies suggest that UTI is incorrectly 
diagnosed in as many as 40% of hospitalized older people.3 The increasing prevalence 
of health care associated infection such as Clostridium difficile and emerging antibiotic 
resistance highlights the importance of obtaining a firm diagnosis, treating with appro-
priate antibiotics and avoiding the use of broad spectrum antibiotics.4
There is a paucity of evidence-based guidelines for the management of UTI specifi-
cally in an older population. The aim of this article is to review the current evidence 
on the diagnosis, management, and prevention of UTI in older people.
Epidemiology
Case definitions are central to any discussion about the epidemiology of UTI 
(Table 1). Symptomatic UTI requires the presence of new urinary tract symptoms 
such as   frequency, urgency, dysuria, new incontinence, or costovertebral or   suprapubic 
  tenderness. The diagnosis of UTI is actually very difficult because there are no Clinical Interventions in Aging 2011:6 submit your manuscript | www.dovepress.com
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  currently   available diagnostic techniques for demonstrating 
that bacteria have invaded the tissues of the urinary tract. 
The diagnosis is therefore clinical and is based on symptoms 
or signs of inflammation of the urinary tract. Urine culture 
does not establish the diagnosis of UTI but does aid in the 
selection of appropriate treatment.
A number of factors predispose older patients to UTI. 
Use of urinary catheters and external urine collection devices 
increase the frequency of bacteriuria. Asymptomatic bacte-
riuria is more common in patients with cognitive impairment 
and urinary and fecal incontinence. Neurological condi-
tions such as cerebrovascular disease, Alzheimer’s disease, 
and Parkinson’s disease are all common in later life and 
are associated with impaired bladder emptying.5,6 Patients 
with diabetes mellitus also have increased prevalence of 
asymptomatic bacteriuria with contributing factors including 
neurogenic bladder and poor glycemic control.7
In women, postmenopausal estrogen deficiency has been 
linked with recurrent UTI.8 Cystoceles, significant postvoid-
ing residual urine volumes, and incontinence are all associ-
ated with recurrent UTI.8 In men, prostatic disease leads to 
urinary symptoms and urinary retention. Any urological 
condition that can cause obstruction such as stones or tumor 
also increases the risk of urinary infection. Urinary tract 
infection most commonly arises from ascending infection 
via the urethra with Gram-negative organisms in the perineal 
region from bowel flora.9
Bacteriuria is defined as the presence of bacteria in urine 
on microscopy or quantitative culture. It is important to 
appreciate that the presence of bacteriuria does not always 
represent disease.10 Pyuria represents the presence of white 
blood cells in urine. White blood cells may be present without 
bacteriuria and are particularly associated with the presence 
of a urinary catheter, stone, tumor, or infection of the lower 
genital tract.10 Urinary tract infections are subclassified into 
complicated and uncomplicated UTI. Complicated UTI 
implies that the urinary tract has a functional or structural 
abnormality but the term also includes all upper UTI and all 
UTI in men (Table 1). Older female patients frequently have 
functional or structural abnormalities of the urinary tract and 
many regard UTI as complicated UTI in this group.11
Diagnosis
Clinical findings
The diagnosis of infection in an older patient is often com-
plicated by the lack of typical symptoms and a clear history. 
Up to one-third of elderly patients do not present pyrexia in 
response to infection.12 The presence of cognitive impair-
ment and communication difficulties can make it difficult to 
obtain an accurate history. Many older patients have chronic 
genitourinary symptoms and it is important to recognize that 
this is not synonymous with infection.8
Many clinicians incorrectly attribute factors such as func-
tional decline, increased confusion, and nonspecific signs and 
symptoms to urinary tract infections and start treatment on 
this basis.2,13,14 In the absence of clear urinary tract localizing 
symptoms and signs, older patients should be systematically 
assessed with a full clinical evaluation performed to arrive 
at a differential diagnosis.2
Juthani-Mehta et al conducted a prospective cohort 
study of nursing home residents in Connecticut to ascertain 
which clinical features are associated with bacteriuria and 
pyuria in uncatheterized nursing home residents.15 Dysuria, 
change in character of urine and change in mental status 
were significantly associated with bacteriuria plus pyuria 
in patients with suspected UTI. Absence of these clinical 
Table 1 Definition of terms
Term Standard definition Application to management of urinary tract infection (UTI)  
in elderly patients
Significant  
bacteriuria
Presence of a specified number  
(usually .105 CFU/mL) of a single 
species of bacteria in a freshly voided,  
midstream specimen of urine.
This level of bacteriuria is significant because it is unlikely that it can  
be explained by contamination of the urine sample with perineal flora.  
It DOES NOT indicate clinically significant bacteriuria. “Significant”  
bacteriuria is often asymptomatic and does not necessarily require  
treatment. Lower levels may sometimes be significant.
Uncomplicated  
urinary tract  
infection
Lower urinary tract infection in an adult  
woman who is not pregnant and has no  
underlying abnormality of the urinary tract  
or indwelling urinary device.
The evidence about effectiveness of short (3 day) courses of treatment   
for UTI only applies to uncomplicated UTIs. All UTIs in males, all UTIs  
associated with urinary catheters, and all UTIs with systemic symptoms   
are complicated UTIs.
Lower urinary  
tract infection
Infection confined to the tissues of the  
bladder or urethra. The presence of  
symptoms or signs of systemic infection  
indicates upper urinary tract infection.
Both nitrofurantoin and fosfomycin only achieve effective  
concentrations in the lower urinary tract infection. These antibiotics  
should not be used to treat patients with systemic symptoms or signs.Clinical Interventions in Aging 2011:6 submit your manuscript | www.dovepress.com
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features   identified residents at low risk of having bacteriuria 
plus pyuria (25.5%), whereas the presence of dysuria plus 
one or both of the other clinical features identified residents 
at high risk of having bacteriuria plus pyuria (63.2%). 
  Participants had a high prevalence of dementia (63.3%) and 
given the high prevalence of bacteriuria in patients with cog-
nitive impairment, altered mental status may not be a useful 
criterion for commencing antibiotics. This study reinforced 
that nonspecific signs, such as change in function, malaise, 
falls, and change in voiding pattern were not significantly 
associated with bacteriura plus pyuria.
Recognizing the diagnostic challenges in this population, 
Loeb et al attempted to develop criteria for initiating antibiot-
ics in patients with bacteriuria in a long-term care setting.16 
This consensus paper suggested that antibiotics should be 
initiated for residents without a urinary catheter with acute 
dysuria alone or fever (defined as temperature above 37.9°C 
or rise of 1.5°C above baseline) and one of the following 
symptoms: new or worsening urgency, frequency, suprapubic 
pain, frank hematuria, costovertebral angle tenderness, or 
urinary incontinence.
Some older patients may have UTI without localizing 
urinary symptoms and these patients cannot always be 
identified. The approach suggested by Nicolle is simply to 
closely monitor such patients and regularly reassess clinical 
features.14
Urine dipstick testing
Few studies have looked specifically at the role of dipstick 
urinalysis in the older population. Most studies on urine 
dipstick testing discuss the sensitivity and specificity of 
the tests.17 While these characteristics are relevant to the 
performance of tests in a population, they are rarely helpful 
for making decisions about individual patients.18 In contrast, 
the positive predictive value (PPV) and negative predictive 
value (NPV) of a test are helpful in estimating the probability 
of disease in patients with positive and negative tests. Bent 
et al used likelihood ratios to express the post-test probability 
of a female patient having an uncomplicated UTI.19 In a 
systematic review based on studies in young women, nitrite 
and leucocyte esterase positive urinalysis had a positive 
likelihood ratio of 4.2. A negative urinalysis result had a 
likelihood ratio of UTI of 0.3. However this review was 
not specific to older people so the conclusions may not be 
transferable.
Sundvall and Gunnarsson evaluated the NPV of combined 
nitrite and leucocyte esterase dipstick analysis in predict-
ing the presence of pathogenic bacteria in elderly nursing 
home patients.20 They addressed shortcomings in previous 
studies by including both visual and analyzer reading of 
dipsticks as well as providing data about the separate perfor-
mance of tests for nitrites and leukocytes in the identification 
of specific bacteria in addition to any bacteria. However, 
an important weakness of the study is its failure to provide 
separate data for symptomatic versus asymptomatic patients, 
and the case definition for significant bacteriuria implies that 
symptomatic patients were included.
According to their statistical analysis, ruling in or rul-
ing out bacteriuria was considered possible where the point 
estimate of PPV/NPV was $85% with a lower confidence 
interval (CI) of $80%. The authors concluded that the most 
reliable way to rule out bacteriuria was to identify patients in 
whom both tests were negative. However, the authors con-
cede that no combination of dipstick test results can be used 
to rule in bacteriuria. The combination of negative leukocyte 
and nitrite test had a NPV of 88% (CI: 84%–92%), however 
the results show interpretation is further influenced by the 
definition of a negative test because the PPV is only 51% if 
a positive test is defined as .0 (Figure 1). Our interpretation 
of these results is that dipstick testing is likely to add little if 
anything to clinical diagnosis. With a positive test, the prob-
ability of bacteriuria was between 51% and 73%, and with 
a negative test it was between 9% and 21%. These results 
are similar to the positive and negative predictive value of 
clinical symptoms and signs without stick testing.
In the study by Juthani-Mehta et al, dysuria – change 
in character of urine – and change in mental status were 
significantly associated with the combined outcome of 
bacteriuria plus pyuria.15 Absence of these clinical features 
identified residents at low risk of having bacteriuria plus 
pyuria (25.5%), whereas the presence of dysuria plus one or 
both of the other clinical features identified residents at high 
risk of having bacteriuria plus pyuria (63.2%). Supporters 
of dipstick testing need to provide evidence that these tests 
meaningfully improve clinical prediction of bacteriuria in 
symptomatic patients.
Urine culture
Significant bacteriuria is commonly defined as greater than 
105 colony forming units/mL of a single bacterial species in a 
freshly voided sample of urine.10 However, case definitions in 
studies of UTI are often much more complex, for example:
“A culture with growth of potentially pathogenic bacteria 
was normally considered positive if the number of colony 
forming units per liter (CFU/mL) was .105. In case of spe-
cific signs of possible UTI such as positive nitrite dipstick, Clinical Interventions in Aging 2011:6 submit your manuscript | www.dovepress.com
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leukocyte esterase dipstick .1, fever, frequency, urgency or 
dysuria, the cut-off point was .103 for patients harbouring 
Escherichia coli and male patients with Klebsiella species 
and Enterococcus faecalis. For symptomatic women with 
the two latter species, the cut-off level was .104”
Sundvall and Gunnarsson20
Obtaining urine cultures can be difficult in some older 
people. Guidelines suggest that an in-and-out catheter may 
be the most reliable way of obtaining a urine sample in the 
female population if a voided sample cannot be obtained.21 
Urine culture by needle aspiration of the bladder is the gold 
standard method for diagnosing bacteriuria, but is rarely 
used in older people.10 Urine cultures should not be sent in 
individuals who are asymptomatic.10,21 Urine should also not 
be sent for culture on the basis of positive urine dipsticks if 
no symptoms are evident.22
Asymptomatic bacteriuria
Asymptomatic bacteriuria is defined as the presence of 
bacteria in urine on microscopy or quantitative culture in a 
specimen obtained from a patient who does not have typical 
symptoms of a urinary tract infection.10 This requires confir-
mation by two consecutive samples. Studies have suggested 
a prevalence rate of 25%–50% of women and 15%–40% of 
men without catheters amongst nursing home residents.22 
Risk factors associated with asymptomatic bacteriuria 
include institutionalization, presence of a urinary catheter, 
female sex, increasing age, and diabetes.10
It is widely recognized that asymptomatic bacte-
riuria should not be treated with antibiotics in the elderly 
population.10,22 Treating asymptomatic bacteriuria does not 
reduce mortality and can cause harm.23,24 Guidelines sug-
gest that for every three people treated with antibiotics, one 
will come to harm (CI: 2–10).10 Evidence also suggests that 
treating asymptomatic bacteriuria in nursing home patients 
who have chronic stable incontinence does not improve 
incontinence in the short-term.25
Catheter-associated UTI
Catheter-associated UTIs account for a high proportion of 
health care associated infection and are common among 
the older population in long-term care. In ambulatory 
patients, single catheter insertion is associated with urinary 
tract infection in 1%–2% of patients. Indwelling urinary 
catheters lead to almost universal bacteriuria within 
3–4 days of catheterization. Catheterization allows for the 
formation of a biofilm between the catheter and urethral 
mucosa. A biofilm is the aggregation of microorganisms 
that form a structure on solid surfaces.26,27 The greatest 
risk factor for catheter-associated UTI is duration of 
catheterization.8
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Figure 1 Negative predictive value (NPv) and positive predictive value (PPv) for dipstick urine testing for diagnosis of bacteriuria in a nursing home population. Test 
characteristics of a positive leukocyte esterase and/or a positive nitrite dipstick were compared to urine culture. These results were for visual reading of the dipstick; results 
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The diagnosis of catheter associated UTI in the older 
population is difficult and clinical signs and symptoms are 
often absent. Guidelines suggest symptoms or signs alone 
should not be relied upon for predicting the likelihood of 
catheter associated UTI.10 Catheter samples of urine should 
only be sent if the patient shows signs of sepsis, recogniz-
ing that most catheterized patients will have bacteriuria.10,22 
Urinary catheters should ideally be removed and a culture 
then acquired from a freshly inserted catheter prior to com-
mencing antimicrobials.26
Loeb et al recommended minimum criteria for initiating 
antibiotics in older patients in long-term care with catheters.16 
These criteria included presence of fever .37.9°C or 1.5°C 
above baseline temperature, new costovertebral tenderness, 
rigors without obvious cause, or new onset of delirium. SIGN 
(Scottish Intercollegiate Guidelines Network) guidelines 
advocate that in patients with indwelling urinary catheters 
who are pyrexial, the clinician should exclude other sources 
of infection and look for any localizing signs such as supra-
pubic tenderness or loin pain.10 A sample of urine should 
be cultured to isolate the infective organism and to obtain 
antibiotic sensitivities stating clearly on the request form that 
it is a sample of catheter urine. The severity of infection and 
underlying comorbidities should be taken into consideration 
prior to prescribing antibiotics.
The Infectious Diseases Society of America (IDSA) pub-
lished international clinical practice guidelines in 2009 on 
the diagnosis and management of catheter-associated UTI.26 
These apply to adults over 18 years of age and are not spe-
cific to older people. Similar clinical criteria to Loeb’s were 
identified for diagnosis of catheter associated UTI. New or 
worsening fever, rigors, altered mental state, general malaise, 
or lethargy without other identified causes were identified as 
possible signs and symptoms.
Guidelines suggest that catheters should be replaced prior 
to commencing antibiotic therapy in symptomatic catheter-
ized patients if it has been in situ for longer than 1 week.10,22,26 
IDSA guidelines recommend that catheters that have been in 
use for more than 2 weeks should be changed to try and lead to 
quicker resolution of symptoms and prevent UTI   recurrence.26 
The optimal method of decreasing catheter associated UTI is 
to reduce indwelling catheter use and remove catheters the 
moment they are no longer clinically necessary.
Management of UTI
Antimicrobial prescribing
In an era of antibiotic stewardship, the prescribing of antibiot-
ics is the subject of much scrutiny.28 The trend until recently 
of increasing cases of Clostridium difficile diarrhea has led 
to a shift from broad to narrow spectrum antibiotics.4 The 
prevalence of trimethoprim resistance in the Tayside popula-
tion in Scotland has been reported as 27%–28%.29 Given the 
increased problems with resistance and health care associated 
infection, the use of narrow spectrum agents where possible 
is now strongly encouraged.30 The use of narrow spectrum 
agents highlights the necessity for accurate diagnosis and 
the importance of obtaining cultures in the elderly prior to 
commencing antibiotics.31 Local guidelines are now widely 
utilized for prescribing antimicrobials based on local resis-
tance patterns and available agents.
The most common organism isolated depends on popula-
tions studied. E. coli is the most frequent organism isolated 
in the older population.1,11,32 Gram-negative agents such 
as Klebsiella pneumoniae and Proteus mirabilis are also 
common.
The management of uncomplicated symptomatic UTI 
in the female population has been the subject of several 
randomized controlled trials. Most studies exclude the very 
elderly and focus on the younger adult population. UK 
guidelines advocate that trimethoprim should be used as the 
first-line antibiotic in uncomplicated symptomatic UTI in 
females.10,23,30 Nitrofurantoin is an alternative, although it 
should not be used in those with renal impairment due to the 
inability to achieve necessary concentrations in the urine and 
possibility of toxic levels in the plasma.10 European guidelines 
are now moving towards fosfomycin trometamol or nitro-
furantoin as first- and second-line agents with trimethoprim 
or cotrimoxazole advised only in areas where resistance rates 
for E. coli are less than 20%.8
The Infectious Disease Society of America published 
guidelines on the management of UTIs in females, which are 
currently under review.33 Trimethoprim-sulfamethoxazole 
was advocated as the first-line agent for acute symptom-
atic lower urinary tract infection in females for 3 days. 
  Trimethoprim and ofloxacin were proposed as suitable alter-
natives. Fluoroquinolones were not recommended as first-
line therapy unless there was a high level (.10%–20%) of 
trimethoprim or trimethoprim-sulfamethoxazole resistance. 
They also identified that nitrofurantoin and fosfomycin use 
may be more prominent if increasing resistance emerged. With 
growing concern over fluoroquinolone use and resistance, a 
group reviewed the recommendations for empiric treatment 
of UTI.34 They agreed that trimethoprim-  sulfamethoxazole 
should continue to be used as first-line treatment in uncom-
plicated UTI if the patient has not received any antibiotics in 
the past 3 months, had no hospitalizations, and there is ,20% Clinical Interventions in Aging 2011:6 submit your manuscript | www.dovepress.com
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resistance to trimethoprim-sulfamethoxazole locally. They 
recommended considering nitrofurantoin or fosfomycin 
if these criteria were not fulfilled.   Fluoroquinolones were 
recommended only if severe symptoms were present and 
the patient had received previous antibiotic therapy in the 
last 3 months and lived in an area with .20% resistance to 
trimethoprim-sulfamethoxazole. These guidelines were not 
specific to the older population.
A 3-day course of trimethoprim is recommended for 
women and a 7-day course for men.22 A Cochrane review 
examined evidence for duration of antibiotic therapy for 
uncomplicated, symptomatic lower UTIs in older   women.35 
Fifteen randomized controlled studies (1644 elderly females) 
were reviewed and the authors concluded that short course 
antibiotics of 3–6 days could be adequate for treating 
uncomplicated UTI in older women. A need for more stud-
ies looking at optimum duration of narrow spectrum agents 
was highlighted.
Most published guidelines for management of upper 
UTIs still recommend using quinolones as first-line agents.10 
The need to review such guidelines has been highlighted.4 
The IDSA guidelines recognized that there were few good, 
recent clinical studies of treatment in pyelonephritis and 
upper UTIs.33 They advised that severe pyelonephritis 
should be treated with intravenous fluoroquinolones or an 
aminoglycoside with or without ampicillin or an extended 
spectrum cephalosporin with or without an   aminoglycoside. 
These guidelines again were not specific to the elderly 
population.
Our local guidelines in Tayside, Scotland advocate that 
lower UTIs in females should be managed with trimethoprim 
for 3 days and males should receive 14 days of trimethoprim. 
Complicated UTIs, including upper UTI and bacteremic UTI, 
are treated with intravenous amoxicillin and gentamicin. 
Co-trimoxazole is used as an alternative in penicillin allergic 
patients in conjunction with gentamicin.
Problems with antimicrobial resistance can also be 
tackled with more judicious use of antibiotics. Research 
has sought to uncover why doctors treat asymptomatic bac-
teriuria and also to identify ways of reducing antimicrobial 
prescribing in the older population.13,36 Loeb et al conducted a 
cluster randomized controlled trial to assess whether the use 
of an algorithm to aid diagnosis and management of urinary 
tract infections could reduce antimicrobial prescribing in 
nursing home residents in Canada.36 This used educational 
material aimed at nurses and physicians working in nursing 
homes and set out a diagnostic algorithm based on previous 
consensus criteria for diagnosing UTIs in catheterized and 
  noncatheterized long-term care patients.16 The study was 
underpowered to assess significant differences in hospital 
admission and death between the group randomized to inter-
vention and the usual care group. It did however demonstrate 
that using an algorithmic approach reduced antimicrobial 
prescribing for suspected UTI.36
If patients do not have systemic signs there is no need to 
start antibiotics immediately. In a randomized trial of five 
management strategies for uncomplicated UTI in nonpreg-
nant women delaying antibiotics to see if symptoms resolved 
spontaneously did not increase duration or severity of symp-
toms and significantly reduced antibiotic use. Symptom 
score was 2.11 for delayed antibiotics vs 2.15 for immediate 
antibiotics but there was a 20% reduction in antibiotic use. 
This trial was done in younger women (mean age 40) but 
the results are relevant to older women, especially in care 
homes where they can be observed closely.37
Prevention of UTI
Cranberry products
Cranberries have long been considered to have a role in 
reducing UTIs. The exact mechanism has been disputed. 
Cranberries contain tannins called proanthocyanidins, which 
prevent adherence of P-fimbriated E. coli to uroepithelial 
cells on the bladder wall.38
A Cochrane review examined the evidence for the use 
of cranberry in the prevention of UTI in susceptible popu-
lations.39 This identified ten randomized controlled trials 
using cranberry for the prevention of UTI. Four studies 
were included in the meta-analysis and demonstrated that 
cranberry significantly reduced the incidence of UTI at 1 year 
compared to placebo. Studies included a variety of popula-
tions examined and cranberry was more effective in younger 
adult females with recurrent UTI than in older people.
McMurdo et al conducted a randomized, placebo-con-
trolled double-blind trial examining whether cranberry juice 
reduced UTI in elderly hospitalized patients in Scotland.40 
The primary outcome was time to onset of first symptomatic 
UTI. 376 patients were randomized making this one of the 
largest available randomized controls examining the effect 
of cranberry juice. This study had a lower symptomatic 
infection rate than that observed during the pilot phase and 
so was underpowered to demonstrate a significant difference 
between cranberry and placebo. The number of E. coli UTI 
was significantly lower in the cranberry group compared to 
placebo.
SIGN guidelines recommended that females with 
recurrent UTI should take cranberry products to decrease Clinical Interventions in Aging 2011:6 submit your manuscript | www.dovepress.com
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  frequency of recurrence.10 Capsules were advocated as 
easier to take than juice. Cranberry products are not recom-
mended for patients taking warfarin as cranberry is thought 
to   potentiate the effects of warfarin. The United Kingdom 
Committee on Safety of Medicines issued an alert in 2004 
about this based on a series of case reports.41 However, 
subsequent work suggests that there is no significant inter-
action between warfarin and high-dose cranberry juice.42
Prevention of catheter associated UTI
Catheter associated UTI is the most common health care 
associated infection throughout the world and is common in 
long-term care facilities. Urinary catheterization should be 
avoided unless there is a clear clinical indication. Catheters 
should be avoided where possible for the management of 
incontinence. Staff should also be trained on indications 
for catheterization and written protocols should be put in 
place.26,27 Catheters should also be removed the moment that 
they are no longer required.
Alternatives to indwelling urethral catheters should be 
considered. Condom catheters are associated with a lower 
incidence of bacteriuria, however their use is sometimes 
difficult in confused patients.27 A Cochrane review on short-
term urinary catheterization in adults found that suprapubic 
catheterization was associated with less bacteriuria than 
urethral catheterization.43 Suprapubic catheterization does 
carry a small risk of visceral injury on insertion through 
the abdominal wall. Intermittent catheterization was also 
associated with a lower risk of bacteriuria when compared 
to indwelling catheterization in this review, however studies 
included were mainly in an elective orthopedic setting.43
Guidelines suggest that antibiotic prophylaxis should not 
be used to prevent catheter associated UTI in catheterized 
patients.10 Although prophylaxis may decrease the incidence 
of asymptomatic bacteriuria in catheterized patients, it 
increases the risk of antimicrobial resistance.
Conclusion
Urinary tract infections present a significant problem in 
both hospital medicine and general practice. The burden 
of infection is high and there are many challenges in diag-
nosis and management. Several studies have identified the 
need for better education on asymptomatic bacteriuria and 
presentation of UTI in the elderly population. Symptomatic 
infections are often difficult to diagnose in older popula-
tions where there are high levels of cognitive impairment 
and communication difficulties, such as amongst residents 
of institutional care.
A strategy of observing patients for possible symptoms before 
initiating antibiotics have been advocated, although recognizing 
this may not always be practical in a primary care setting. Reducing 
inappropriate prescribing of antibiotics for asymptomatic bacte-
riuria is likely to reduce antimicrobial resistance.
With emerging knowledge on antibiotic resistance and 
health care-associated infection, guidelines need to be 
updated to reflect the need to prescribe narrow spectrum 
agents when available and avoid empirical use of broad 
spectrum antibiotics.
Key points
•	 Urinary tract infections are overdiagnosed and overtreated 
in older people.
•	 Diagnosis of UTI in an older person requires the presence 
of new urinary symptoms.
•	 Asymptomatic bacteriuria is very common in later life 
and should not be screened for or treated.
•	 Local guidelines and antibiotic policies should be used 
for management of UTI.
•	 Narrow spectrum antibiotics are generally preferable to 
broad spectrum agents.
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